More than 13% of Northwell Health staff have COVID-19 antibodies, serology tests show

Large-scale testing of front-line healthcare providers at New York City-Northwell Health found 13 percent of staff had COVID-19 antibodies, according to research published Aug. 6 in The Journal of the American Medical Association. 

Advertisement

Of Northwell’s 72,000 employees, 40,329 were screened for antibodies between April 20 to June 23. Northwell Health COVID-19 Research Consortium, along with Manhasset, N.Y.-based Feinstein Institutes for Medical Research, analyzed the data and found the employee serology tests showed more than 13 percent of healthcare providers tested positive for antibodies. 

Healthcare personnel reported demographics, work location, and level of suspicion of virus exposure. High levels of suspicion and prior positive diagnostic testing were stronger indicators of positive results.  

“As researchers, it’s important to us to share findings from our antibody testing, and we are pleased to know that the personal protective equipment we used was successful in protecting the vast majority of our staff,” said Karina Davidson, PhD, professor and senior vice president at the Feinstein Institutes. 

More articles on infection control:
COVID-19 infection control failures at Pennsylvania facility put 128 residents in immediate jeopardy
Flu shot may reduce Alzheimer’s risk, study finds
23 staff, 13 patients positive for COVID-19 after Massachusetts hospital employee visits virus hot spot

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Infection Control

Advertisement

Comments are closed.